SCHEMBL1700765

SCHEMBL1700765

Cc1cc(C)[nH]c(=O)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29943510 0.77
SCHEMBL18701493 0.75 CA1 (0.43)
SCHEMBL2962199 0.74
SCHEMBL3995513 0.74
SCHEMBL1092933 0.74
SCHEMBL25112082 0.74
SCHEMBL24818436 0.74
SCHEMBL11929402 0.74
SCHEMBL589096 0.74
SCHEMBL2884356 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114409636-B Quinazolinone compound or pharmaceutically acceptable salt thereof, and preparation method and application thereof 沈阳药科大学 2023-04-18 CN claimed
US-20250311689-A1 SEEDLING GERMINATION AND GROWTH CONDITIONS PIONEER HI-BRED INTERNATIONAL, INC. (US) 2025-10-09 US disclosed
US-12344618-B2 Heterotricyclic derivative compound and use of same HANMI PHARMACEUTICAL CO., LTD. (KR) 2025-07-01 US disclosed
CN-119698422-A Aza condensed ring compound, preparation method and medical application thereof 苏州爱科百发生物医药技术有限公司 2025-03-25 CN disclosed
US-20240217952-A1 TREATMENT OF GRAFT-VERSUS-HOST DISEASE WITH INHIBITORS OF BET FAMILY BDII BROMODOMAIN POSEIDON INNOVATION 1, INC. 2024-07-04 US disclosed
WO-2024067660-A1 AZA-FUSED RING COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF IN MEDICINE 苏州爱科百发生物医药技术有限公司 2024-04-04 WO disclosed
EP-3356345-B1 HETEROARYL DERIVATIVES AS SEPIAPTERIN REDUCTASE INHIBITORS MAX PLANCK GESELLSCHAFT (DE) 2023-11-08 EP disclosed
CN-116888100-A High-activity HPK1 kinase inhibitor 杭州阿诺生物医药科技有限公司 2023-10-13 CN disclosed
WO-2023192989-A2 PHTHALAZINONE COMPOUNDS AS PARP7 INHIBITORS AZKARRA THERAPEUTICS, INC. (US) 2023-10-05 WO disclosed
CN-114409636-B Quinazolinone compound or pharmaceutically acceptable salt thereof, and preparation method and application thereof 沈阳药科大学 2023-04-18 CN disclosed
US-7553809-B2 Fc receptor modulators and uses thereof ILEXUS PTY LIMITED (AU) 2009-06-30 US disclosed
US-7189855-B2 Process for production of phenoxy-substituted 2-pyridone compounds SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-03-13 US disclosed
US-7189855-B2 Process for production of phenoxy-substituted 2-pyridone compounds SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-03-13 US disclosed
US-7189855-B2 Process for production of phenoxy-substituted 2-pyridone compounds SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-03-13 US disclosed
US-20050154210-A1 Process for production of phenoxy-substituted 2-pyridone compounds SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2005-07-14 US disclosed
EP-1538145-A1 PROCESS FOR PRODUCTION OF PHENOXY-SUBSTITUTED 2-PYRIDONE COMPOUNDS Sumitomo Chemical Company, Limited (JP) 2005-06-08 EP disclosed
US-4451469-A Selected 6-alkyl-and 4,6-dialkyl-2(1H)-pyridinones as cardiotonics STERLING DRUG INC. (US) 1984-05-29 US disclosed
US-4205174-A Process for the production of 6-substituted 4-methyl-2-pyridones LONZA, LTD. (CH) 1980-05-27 US disclosed
US-3968118-A Process for the manufacture of 1-hydroxy-2-pyridones HOECHST AKTIENGESELLSCHAFT (DT) 1976-07-06 US disclosed
US-3957997-A Anticoccidial complexes of 4,4'-dinitrocarbanilides MERCK & CO., INC. (US) 1976-05-18 US disclosed